Equity markets on Thursday experienced marked intraday swings, with technology and memory-related equities producing many of the larger advances on the session and several corporate-specific announcements triggering outsized declines among mid- and large-cap issues.
Mega-cap movers
The largest market-capitalization names showed a concentration of gains in companies tied to semiconductors, memory and related equipment. Notable moves in this group included:
- SanDisk Corp-Exch (SNDK) +11.05%
- Marvell Technology Group Ltd (MRVL) +12.15%
- Intel Corp (INTC) +9.95%
- Micron Tech (MU) +9.0%
- Kla-tencor Corp (KLAC) +8.92%
- Texas Instru (TXN) +6.34%
- Qualcomm Inc (QCOM) +6.84%
- Lam Research Corp (LRCX) +5.82%
- Western Digital (WDC) +4.23%
- SpaceX (SPCX) -6.35%
Several of the largest percentage increases clustered around companies with direct exposure to memory, logic and capital equipment supply chains.
Large-cap movers
In the $10 billion to $200 billion market-cap range, the session was mixed with notable headlines shaping performance. Accenture Ltd (ACN) fell after a transaction disclosure and other large-cap names posted gains:
- Accenture Ltd (ACN); Accenture to acquire majority stake in Dragos for $4.2 billion -18.47%
- Entegris Inc. (ENTG) +12.21%
- Astera Labs (ALAB) +11.71%
- Good Works Acquisition (CIFR) +11.27%
- Super Micro Compu (SMCI) +11.03%
- DRAM (DRAM) +10.31%
- Bloom Energy Corp (BE) +8.73%
- Corning Inc (GLW) +9.33%
- Lattice semiconductor (LSCC) +8.33%
- Cognizant Technology Solutio (CTSH); Cognizant integrates ServiceNow AI agents with Neuro platform -9.61%
Two large-cap companies with explicit headlines moved lower on the session: Accenture following the disclosed majority-stake acquisition, and Cognizant after an announcement about ServiceNow AI agent integration with its Neuro platform.
Mid-cap movers
The mid-cap cohort saw a mix of substantial gains and steep declines, with several companies posting double-digit percentage changes:
- SNXX (SNXX) +21.4%
- MUU (MUU) +17.83%
- Smart Global Holdings Inc (PENG) +13.66%
- Cree Inc. (WOLF) +12.45%
- Diodes Inc (DIOD) +10.76%
- Ekso Bionics Holding (CHRN) +14.02%
- Bctg Acquisition Corp (TNGX) -11.61%
- Legend Biotech Corp (LEGN); Legend Biotech launches $225 million public share offering -16.36%
- Regencell Bioscience Holdings (RGC) -13.9%
- Novocure Ltd (NVCR); Novocure’s glioblastoma trial fails primary endpoint -18.26%
Among mid-caps, the biotech and life-sciences subset accounted for several of the sharper falls, where capital-raising actions and clinical-trial outcomes were cited.
Small-cap movers
Smaller market-cap names produced the most extreme percentage moves on the day, led by specific corporate developments and market responses to company news:
- Longview Acquisition (BFLY); Butterfly Network supplies ultrasound tech for Midjourney scanner +45.89%
- Kardigan Inc (KARD); Kardigan prices IPO at $16 per share, raising $400 million +25.88%
- MVLL (MVLL) +24.04%
- Horizon Quantum Holdings (HQ) +22.83%
- INTW (INTW) +19.25%
- Smith & Wesson (SWBI); Smith & Wesson surges 16% as Q4 earnings, revenue top estimates +17.95%
- MULL (MULL) +17.91%
- GRAVITY Co. (GRVY) +17.62%
- Methode Electronics Inc (MEI) +16.68%
- Intec Pharma Ltd (INDP) -15.23%
Newsflow tied to initial public offering pricing, product supply agreements and earnings beats drove many of the outsized small-cap moves.
Summary
Thursday's trading featured pronounced dispersion across market caps, with semiconductor and memory-related stocks registering many of the largest gains among mega- and large-caps, while discrete corporate actions and trial results produced some of the heaviest losses in mid- and small-cap names.
Key points
- Semiconductor, memory and equipment-related firms dominated positive moves in the largest-cap cohort, impacting technology and industrial supply-chain exposures.
- Company-specific headlines - including acquisitions, clinical-trial outcomes and share offerings - were primary drivers of steep declines among several large- and mid-cap issuers, affecting professional services, biotech and life-sciences sectors.
- Small-cap activity was characterized by large percentage swings tied to IPO pricing, product supply arrangements and quarterly results, with implications for healthcare, defense-related consumer products and niche technology providers.
Risks and uncertainties
- Corporate transaction announcements and disclosed acquisitions can depress share prices in the short term for the acquirer or target, impacting professional services and cybersecurity-related firms.
- Clinical-trial failures and public share offerings can materially affect biotech and life-sciences companies, creating heightened downside risk for investors in that sector.
- Small-cap stocks exhibited extreme intraday volatility tied to single announcements, exposing investors to sharp gains or losses and amplifying liquidity and execution risk in smaller market-cap securities.
The moves documented above reflect the session's reported percentage changes and the company disclosures cited during trading. Market participants should consider how concentrated sector moves and company-specific events can alter portfolio exposure and short-term liquidity dynamics.